Defunct Company
Total Trials
4
As Lead Sponsor
0
As Collaborator
Total Enrollment
34
NCT01856868
Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study)
Phase: Phase 1/2
Role: Collaborator
Start: May 31, 2013
Completion: Sep 30, 2018
NCT02660112
(+) Epicatechin to Treat Friedreich's Ataxia
Phase: Phase 2
Start: Sep 30, 2016
Completion: Dec 30, 2018
NCT02964377
Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents
Start: Nov 30, 2016
Completion: Jul 31, 2018
NCT03236662
(-)- Epicatechin Becker Muscular Dystrophy
Completion: Dec 31, 2017